Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer

Fig. 5

The nomograms and risk stratification of stage III-IV LCNEC and SCLC. a nomogram of LCNEC. b risk stratification of LCNEC. c nomogram of SCLC. d risk stratification of SCLC. *The cut-off point for risk stratification of LCNEC was 168 calculated by the nomogram. The cut-off point for risk stratification of SCLC was 195. Abbreviation: LCNEC, large cell neuroendocrine carcinoma; SCLC, small cell lung cancer

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us